搜索临床试验以:Locally Advanced Breast Cancer Neoadjuvant Endocrine
总计118302个结果
-
Baylor Breast Care CenterGlaxoSmithKline完全的
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
City of Hope Medical Center完全的
-
Hospices Civils de Lyon完全的
-
Cancer Institute and Hospital, Chinese Academy...未知
-
National Cancer Centre, Singapore完全的
-
Second Affiliated Hospital, School of Medicine,...完全的
-
The First Affiliated Hospital with Nanjing Medical...未知
-
Instituto Nacional de Cancer, BrazilDana-Farber Cancer Institute完全的三阴性乳腺癌患者
-
Oxford University Hospitals NHS TrustUniversity of Oxford完全的
-
Unity Health TorontoHoffmann-La Roche未知
-
Susanne Crocamo完全的
-
Cancer Institute and Hospital, Chinese Academy...未知
-
SCRI Development Innovations, LLCEisai Inc.完全的
-
Yonsei University完全的
-
Merrimack PharmaceuticalsSanofi完全的
-
Washington University School of Medicine终止
-
Cancer Research UK完全的乳腺癌 | 卵巢癌 | brca1突变携带者 | brca2突变携带者英国
-
King Faisal Specialist Hospital & Research Center完全的
-
University of ChicagoRoche Pharma AG; Breast Cancer Research Foundation终止
-
Dartmouth-Hitchcock Medical Center终止
-
National Cancer Institute (NCI)完全的IIIA期乳腺癌 | IIIB期乳腺癌 | 男性乳腺癌 | 炎性乳腺癌 | 成人实体瘤美国
-
Ontario Clinical Oncology Group (OCOG)完全的
-
SCRI Development Innovations, LLCBristol-Myers Squibb; Genentech, Inc.完全的
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)终止
-
AstraZeneca终止肿瘤 | 乳腺癌 | 乳腺肿瘤巴西, 捷克共和国, 大韩民国, 墨西哥, 秘鲁, 波兰, 俄罗斯联邦, 南非, 英国, 菲律宾, 乌克兰, 芬兰, 加拿大, 台湾, 印度, 泰国, 美国, 日本
-
EMD Serono终止
-
German Breast GroupBoehringer Ingelheim完全的
-
European Organisation for Research and Treatment...Swiss Group for Clinical Cancer Research; Swedish Breast Cancer Group; Anglo Celtic Cooperative...完全的
-
Washington University School of MedicineNovartis; Pfizer完全的
-
Cancer Clinical Trials Unit, Scotland完全的
-
King Faisal Specialist Hospital & Research Center完全的
-
Instituto Nacional de Cancerologia de MexicoInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran未知